For the readers interested in the stock health of ChromaDex Corporation (CDXC). It is currently valued at $7.53. When the transactions were called off in the previous session, Stock hit the highs of $8.26, after setting-off with the price of $7.76. Company’s stock value dipped to $7.50 during the trading on the day. When the trading was stopped its value was $8.58.
Recently in News on May 6, 2021, ChromaDex Corporation Reports First Quarter 2021 Financial Results. Tru Niagen® Revenue for the Three-Month Period Ended March 31, 2021 Totals $12.4 Million, up 12% Year-over-Year, with Total Company Revenue of $14.7 Million and Gross Margin of 62.9%. You can read further details here
ChromaDex Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $23.66 on 02/25/21, with the lowest value was $4.52 for the same time period, recorded on 01/12/21.
ChromaDex Corporation (CDXC) full year performance was 36.41%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ChromaDex Corporation shares are logging -68.17% during the 52-week period from high price, and 97.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.82 and $23.66.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1302115 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ChromaDex Corporation (CDXC) recorded performance in the market was 56.87%, having the revenues showcasing 42.61% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 582.90M, as it employees total of 110 workers.
ChromaDex Corporation (CDXC) in the eye of market guru’s
During the last month, 0 analysts gave the ChromaDex Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.75, with a change in the price was noted +2.03. In a similar fashion, ChromaDex Corporation posted a movement of +36.91% for the period of last 100 days, recording 2,563,388 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CDXC is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
ChromaDex Corporation (CDXC): Stocks Technical analysis and Trends
Raw Stochastic average of ChromaDex Corporation in the period of last 50 days is set at 2.55%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 13.82%. In the last 20 days, the company’s Stochastic %K was 43.25% and its Stochastic %D was recorded 50.13%.
If we look into the earlier routines of ChromaDex Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 56.87%. Additionally, trading for the stock in the period of the last six months notably improved by 57.53%, alongside a boost of 36.41% for the period of the last 12 months. The shares increased approximately by -15.20% in the 7-day charts and went up by -22.21% in the period of the last 30 days. Common stock shares were driven by 42.61% during last recorded quarter.